(Q40939020)

25 September 2017

Evolution of the Radiation Therapy Oncology Group clinical trials for head and neck cancer (English)

1 reference

25 September 2017

Fu KK

1

1 reference

25 September 2017

Cooper JS

2

1 reference

25 September 2017

Marcial VA

3

1 reference

25 September 2017

Laramore GE

4

1 reference

25 September 2017

Pajak TF

5

1 reference

25 September 2017

Jacobs J

6

1 reference

25 September 2017

Al-Sarraf M

7

1 reference

25 September 2017

Forastiere AA

8

1 reference

25 September 2017

Cox JD

9

1 reference

25 September 2017

language of work or name

English

0 references

publication date

1 June 1996

1 reference

International Journal of Radiation Oncology Biology Physics

25 September 2017

1 reference

25 September 2017

35

1 reference

25 September 2017

425-438

1 reference

25 September 2017

3

1 reference

Chemo-radiotherapy in patients with locally advanced nasopharyngeal carcinoma: a radiation therapy oncology group study

25 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2896%2980003-4

7 January 2021

Concomitant boost radiotherapy schedules in the treatment of carcinoma of the oropharynx and nasopharynx

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2896%2980003-4

7 January 2021

Combined postoperative radiotherapy and weekly cisplatin infusion for locally advanced squamous cell carcinoma of the head and neck: preliminary report of a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2896%2980003-4

7 January 2021

Treatment of supraglottic cancer by radical high dose radiotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2896%2980003-4

7 January 2021

Comparison of microscopic vascularity in benign and malignant prostate tissue

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2896%2980003-4

7 January 2021

Recursive partitioning analysis of 2105 patients treated in Radiation Therapy Oncology Group studies of head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2896%2980003-4

7 January 2021

Second malignancies in patients who have head and neck cancer: incidence, effect on survival and implications based on the RTOG experience

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2896%2980003-4

7 January 2021

The relationship of nasopharyngeal carcinomas and second independent malignancies based on the Radiation Therapy Oncology Group experience

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2896%2980003-4

7 January 2021

Interruptions adversely affect local control and survival with hyperfractionated radiation therapy of carcinomas of the upper respiratory and digestive tracts. New evidence for accelerated proliferation from Radiation Therapy Oncology Group Protocol

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2896%2980003-4

7 January 2021

ASTRO plenary: interfraction interval is a major determinant of late effects, with hyperfractionated radiation therapy of carcinomas of upper respiratory and digestive tracts: results from Radiation Therapy Oncology Group protocol 8313

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2896%2980003-4

7 January 2021

Dose-response for local control with hyperfractionated radiation therapy in advanced carcinomas of the upper aerodigestive tracts: preliminary report of radiation therapy oncology group protocol 83-13.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2896%2980003-4

7 January 2021

The value of adjuvant misonidazole in the definitive irradiation of advanced head and neck squamous cancer: an RTOG pilot study (#78-02)

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2896%2980003-4

7 January 2021

Failure of misonidazole-sensitized radiotherapy to impact upon outcome among stage III-IV squamous cancers of the head and neck

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2896%2980003-4

7 January 2021

Adjuvant intravenous methotrexate or definitive radiotherapy alone for advanced squamous cancers of the oral cavity, oropharynx, supraglottic larynx or hypopharynx

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2896%2980003-4

7 January 2021

Multidrug chemotherapy (vincristine-bleomycin-methotrexate) followed by radiotherapy in inoperable carcinomas of the head and neck A pilot study of the Radiation Therapy Oncology Group

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2896%2980003-4

7 January 2021

What Is the Evidence That Tumors Are Angiogenesis Dependent?

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2896%2980003-4

7 January 2021

Flow cytometric quantification of the proliferation-associated nuclear antigen p105 and DNA content in advanced head & neck cancers: results of RTOG 91-08

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2896%2980003-4

7 January 2021

Randomized phase I/II trial of two variants of accelerated fractionated radiotherapy regimens for advanced head and neck cancer: results of RTOG 88-09.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2896%2980003-4

7 January 2021

Late effects of hyperfractionated radiotherapy for advanced head and neck cancer: long-term follow-up results of RTOG 83-13.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2896%2980003-4

7 January 2021

Intratumoral microvessel density and p53 protein: correlation with metastasis in head-and-neck squamous-cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2896%2980003-4

7 January 2021

The adjuvant treatment of inoperable stage III and IV epidermoid carcinoma of the head and neck with platinum and bleomycin infusions prior to definitive radiotherapy: an RTOG pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2896%2980003-4

7 January 2021

Predicting the response of head and neck cancers to radiation therapy with a multivariate modelling system: an analysis of the RTOG head and neck registry.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2896%2980003-4

7 January 2021

Protection from Radiation-Induced Oral Mucositis by Misoprostol, a Prostaglandin E(1) Analog: A Placebo-Controlled, Double-Blind Clinical Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2896%2980003-4

7 January 2021

T4NOMO glottic cancer: an analysis of dose-time volume factors

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2896%2980003-4

7 January 2021

Management of T3 glottic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2896%2980003-4

7 January 2021

Prevention of second primary tumors with isotretinoin in squamous-cell carcinoma of the head and neck

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2896%2980003-4

7 January 2021

Hyperfractionation versus conventional fractionation in oropharyngeal carcinoma: final analysis of a randomized trial of the EORTC cooperative group of radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2896%2980003-4

7 January 2021

5-year results of cisplatin and fluorouracil infusion in head and neck cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2896%2980003-4

7 January 2021

Combined radiation therapy and surgery in the management of advanced head and neck cancer: final report of study 73-03 of the Radiation Therapy Oncology Group

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2896%2980003-4

7 January 2021

Adjuvant chemotherapy for resectable squamous cell carcinomas of the head and neck: Report of intergroup study 0034

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2896%2980003-4

7 January 2021

Results of an RTOG phase III trial (RTOG 85-27) comparing radiotherapy plus etanidazole with radiotherapy alone for locally advanced head and neck carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2896%2980003-4

7 January 2021

A phase I/II study of the hypoxic cell sensitizer misonidazole as an adjunct to high fractional dose radiotherapy in patients with unresectable squamous cell carcinoma of the head and neck: a RTOG randomized study (#79-04).

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2896%2980003-4

7 January 2021

The effect of local-regional control on distant metastatic dissemination in carcinoma of the head and neck: results of an analysis from the RTOG head and neck database

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2896%2980003-4

7 January 2021

Comparison of low-dose isotretinoin with beta carotene to prevent oral carcinogenesis.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2896%2980003-4

7 January 2021

Strategies for chemoprevention study of premalignancy and second primary tumors in the head and neck.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2896%2980003-4

7 January 2021

Relation of neovascularisation to metastasis of non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2896%2980003-4

7 January 2021

Split-course versus continuous pelvis irradiation in carcinoma of the uterine cervix: a prospective randomized clinical trial of the Radiation Therapy Oncology Group

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2896%2980003-4

7 January 2021

Split-course radiation therapy of carcinoma of the nasopharynx: results of a national collaborative clinical trial of the Radiation Therapy Oncology Group

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2896%2980003-4

7 January 2021

Hyperfractionated photon radiation therapy in the treatment of advanced squamous cell carcinoma of the oral cavity, pharynx, larynx, and sinuses, using radiation therapy as the only planned modality: (preliminary report) by the Radiation Therapy Onc

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2896%2980003-4

7 January 2021

Concomitant cisplatin chemotherapy and radiotherapy in advanced mucosal squamous cell carcinoma of the head and neck. Long-term results of the Radiation Therapy Oncology Group study 81-17

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2896%2980003-4

7 January 2021

"Compensated" split-course versus continuous radiation therapy of carcinoma of the tonsillar fossa. Final results of a prospective randomized clinical trial of the Radiation Therapy Oncology Group

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2896%2980003-4

7 January 2021

Twice-a-day radiotherapy for squamous cell carcinoma of the head and neck: the University of Florida experience

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2896%2980003-4

7 January 2021

New prognostic factors in nasopharyngeal carcinoma. Tumor angiogenesis and C-erbB2 expression

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2896%2980003-4

7 January 2021

Experience with CHART

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2896%2980003-4

7 January 2021

Preoperative chemotherapy in advanced resectable head and neck cancer: final report of the Southwest Oncology Group

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2896%2980003-4

7 January 2021

Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2896%2980003-4

7 January 2021

Adjuvant chemotherapy for advanced head and neck squamous carcinoma. Final report of the Head and Neck Contracts Program

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2896%2980003-4

7 January 2021

Randomized study of preoperative versus postoperative radiation therapy in advanced head and neck carcinoma: long-term follow-up of RTOG study 73-03.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2896%2980003-4

7 January 2021

The primary treatment of advanced vocal cord cancer: laryngectomy or radiotherapy?

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2896%2980003-4

7 January 2021

Intensified concomitant chemoradiotherapy with and without filgrastim for poor-prognosis head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2896%2980003-4

7 January 2021

Tumour angiogenesis in prostatic carcinoma with and without bone marrow metastasis: A morphometric study

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2896%2980003-4

7 January 2021

Local control of oropharyngeal carcinoma after two accelerated hyperfractionation radiation therapy schemes

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2896%2980003-4

7 January 2021

Twice-a-day radiation therapy for cancer of the head and neck

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2896%2980003-4

7 January 2021

Twice-a-day radiation therapy for supraglottic carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2896%2980003-4

7 January 2021

Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2896%2980003-4

7 January 2021

Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2896%2980003-4

7 January 2021

Tumor angiogenesis as a prognostic factor in oral cavity tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2896%2980003-4

7 January 2021

10.1016/S0360-3016(96)80003-4

Identifiers

DOI

1 reference

release_grseyonmobf37gcn3xtz24xeae

25 September 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/grseyonmobf37gcn3xtz24xeae

24 November 2022

mapped directly with Wikidata item

1 reference